Page last updated: 2024-08-24

mci-196 and Dyslipidemia

mci-196 has been researched along with Dyslipidemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dimkovic, N; Locatelli, F; Spasovski, G	1
Apanasovich, N; Dosta, N; Locatelli, F; März, W; Varushchanka, A; Wanner, C; Yakubtsevich, R	1

Trials

2 trial(s) available for mci-196 and Dyslipidemia

Article	Year
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:7 Topics: Bile Acids and Salts; Dose-Response Relationship, Drug; Double-Blind Method; Dyslipidemias; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Function Tests; Male; Middle Aged; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors	2013
Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients. Clinical nephrology, 2014, Volume: 82, Issue:3 Topics: Adult; Aged; Bile Acids and Salts; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Europe; Female; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin; Time Factors; Treatment Outcome; Triglycerides	2014

Article

Year

Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trial.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:7

Topics: Bile Acids and Salts; Dose-Response Relationship, Drug; Double-Blind Method; Dyslipidemias; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Function Tests; Male; Middle Aged; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors

2013

Dyslipidemia in chronic kidney disease: randomized controlled trial of colestilan versus simvastatin in dialysis patients.

Clinical nephrology, 2014, Volume: 82, Issue:3

Topics: Adult; Aged; Bile Acids and Salts; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Europe; Female; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Simvastatin; Time Factors; Treatment Outcome; Triglycerides

2014